IGFBP4, a protein primarily responsible for the modulation of IGF activities, interacts with an array of cellular pathways. Chemicals known to affect these pathways, by extension, can influence the expression, activity, or interactions of IGFBP4. For instance, the PI3K/Akt pathway, known for its pivotal role in IGF signaling, can be targeted by chemicals such as LY294002, Wortmannin, and ZSTK474. By inhibiting this pathway, there's an indirect modulation of the cellular processes that IGFBP4 is involved in. Similarly, the mTOR pathway, another essential player in IGF signaling, can be affected by Rapamycin, leading to potential changes in IGFBP4's operational landscape.
Furthermore, the MAPK/ERK pathway, influenced by chemicals like PD98059 and U0126, plays a role in various cell functions, including growth and differentiation. By altering this pathway, one can infer an indirect impact on IGFBP4's expression or activity. Another facet is the role of AMPK activators like Metformin and A-769662. AMPK, being an energy sensor, has opposing actions to IGF signaling in certain contexts. Therefore, by activating AMPK, there's potential modulation in the cellular environment where IGFBP4 functions. Through these chemicals, we grasp the vast interconnected nature of cellular pathways and the intricate balance that exists, highlighting how they can shape IGFBP4's role within the cell.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
PI3K inhibitor that affects PI3K/Akt signaling. As Akt can modulate IGF signaling, this inhibitor may indirectly influence IGFBP4 levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor that affects the mTOR pathway. Given mTOR's role in IGF signaling, it can indirectly influence IGFBP4's activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MEK inhibitor that impacts the MAPK/ERK pathway. By modulating this pathway, it can influence processes that regulate IGFBP4 expression. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $180.00 $726.00 $1055.00 $3350.00 $5200.00 | 23 | |
AMPK activator. By promoting AMPK activity, which can counteract IGF signaling, it may indirectly modulate IGFBP4 levels. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Another PI3K inhibitor. By impacting the PI3K pathway, it might indirectly adjust the levels or activity of IGFBP4. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 MAPK inhibitor. By affecting the p38 MAPK pathway, it can potentially modulate processes that indirectly impact IGFBP4. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor. JNK pathways interact with IGF signaling, and thus, this inhibitor can indirectly affect IGFBP4-associated functions. | ||||||
Metformin-d6, Hydrochloride | 1185166-01-1 | sc-218701 sc-218701A sc-218701B | 1 mg 5 mg 10 mg | $286.00 $806.00 $1510.00 | 1 | |
An AMPK activator. Given its influence on cellular energy balance, it may indirectly affect IGFBP4 in contexts where IGF signaling is active. | ||||||
ZSTK 474 | 475110-96-4 | sc-475495 | 5 mg | $75.00 | ||
Another PI3K inhibitor. Its influence on the PI3K pathway can have indirect implications on IGFBP4. | ||||||
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $67.00 $306.00 | 2 | |
GSK-3β inhibitor. Given the interplay between GSK-3β and IGF signaling, this inhibitor can have implications on IGFBP4's function. |